Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study

S. Enriquez-Geppert, J. Krc, FJ. O'Higgins, M. Lietz

. 2024 ; 379 (1915) : 20230095. [pub] 20241021

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003116

Executive function deficits, common in psychiatric disorders, hinder daily activities and may be linked to diminished neural plasticity, affecting treatment and training responsiveness. In this pioneering study, we evaluated the feasibility and preliminary efficacy of psilocybin-assisted frontal-midline theta neurofeedback (NF), a neuromodulation technique leveraging neuroplasticity, to improve executive functions (EFs). Thirty-seven eligible participants were randomized into an experimental group (n = 18) and a passive control group (n = 19). The experimental group underwent three microdose sessions and then three psilocybin-assisted NF sessions, without requiring psychological support, demonstrating the approach's feasibility. NF learning showed a statistical trend for increases in frontal-midline theta from session to session with a large effect size and non-significant but medium effect size dynamical changes within sessions. Placebo effects were consistent across groups, with no tasks-based EF improvements, but significant self-reported gains in daily EFs-working memory, shifting, monitoring and inhibition-showing medium and high effect sizes. The experimental group's significant gains in their key training goals underscored the approach's external relevance. A thorough study with regular sessions and an active control group is crucial to evaluate EFs improvement and their specificity in future. Psilocybin-enhanced NF could offer significant, lasting benefits across diagnoses, improving daily functioning. This article is part of the theme issue 'Neurofeedback: new territories and neurocognitive mechanisms of endogenous neuromodulation'.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003116
003      
CZ-PrNML
005      
20250206104042.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1098/rstb.2023.0095 $2 doi
035    __
$a (PubMed)39428872
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Enriquez-Geppert, S $u Department of Clinical and Developmental Neuropsychology, University of Groningen , Groningen, Netherlands $u Department of Biomedical Sciences of Cells & Systems, University Medical Center Groningen , Groningen, Netherlands $1 https://orcid.org/0000000173050111
245    10
$a Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study / $c S. Enriquez-Geppert, J. Krc, FJ. O'Higgins, M. Lietz
520    9_
$a Executive function deficits, common in psychiatric disorders, hinder daily activities and may be linked to diminished neural plasticity, affecting treatment and training responsiveness. In this pioneering study, we evaluated the feasibility and preliminary efficacy of psilocybin-assisted frontal-midline theta neurofeedback (NF), a neuromodulation technique leveraging neuroplasticity, to improve executive functions (EFs). Thirty-seven eligible participants were randomized into an experimental group (n = 18) and a passive control group (n = 19). The experimental group underwent three microdose sessions and then three psilocybin-assisted NF sessions, without requiring psychological support, demonstrating the approach's feasibility. NF learning showed a statistical trend for increases in frontal-midline theta from session to session with a large effect size and non-significant but medium effect size dynamical changes within sessions. Placebo effects were consistent across groups, with no tasks-based EF improvements, but significant self-reported gains in daily EFs-working memory, shifting, monitoring and inhibition-showing medium and high effect sizes. The experimental group's significant gains in their key training goals underscored the approach's external relevance. A thorough study with regular sessions and an active control group is crucial to evaluate EFs improvement and their specificity in future. Psilocybin-enhanced NF could offer significant, lasting benefits across diagnoses, improving daily functioning. This article is part of the theme issue 'Neurofeedback: new territories and neurocognitive mechanisms of endogenous neuromodulation'.
650    _2
$a lidé $7 D006801
650    12
$a neurofeedback $x metody $7 D058765
650    12
$a psilocybin $x farmakologie $7 D011562
650    12
$a exekutivní funkce $x účinky léků $7 D056344
650    _2
$a mužské pohlaví $7 D008297
650    12
$a studie proveditelnosti $7 D005240
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a dospělí $7 D000328
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Krc, J $u Department of Clinical and Developmental Neuropsychology, University of Groningen , Groningen, Netherlands $u Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno , Brno, Czech Republic
700    1_
$a O'Higgins, F J $u Trinity College Institute of Neuroscience, School of Medicine, Trinity College Dublin, The University of Dublin , Dublin, Ireland $u Academic Unit of Neurology, Trinity Biomedical Sciences Institute, School of Medicine, Trinity College Dublin, The University of Dublin , Dublin, Ireland
700    1_
$a Lietz, M $u Department of Clinical and Developmental Neuropsychology, University of Groningen , Groningen, Netherlands $u Department of Medicine, Faculty of Science and Medicine, University of Fribourg , Fribourg, Switzerland
773    0_
$w MED00192920 $t Philosophical transactions - Royal Society of London. Biological sciences $x 1471-2970 $g Roč. 379, č. 1915 (2024), s. 20230095
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39428872 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104037 $b ABA008
999    __
$a ok $b bmc $g 2263085 $s 1239123
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 379 $c 1915 $d 20230095 $e 20241021 $i 1471-2970 $m Philosophical transactions - Royal Society of London. Biological sciences $n Philos Trans R Soc Lond B Biol Sci $x MED00192920
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...